**Core Concept**
The question tests knowledge of antimicrobial resistance, specifically focusing on organisms that exhibit marked resistance to multiple drugs. This concept is crucial in clinical practice, where **multidrug-resistant (MDR) organisms** pose significant challenges in treatment.

**Why the Correct Answer is Right**
Although the correct answer choice is missing, typically, organisms like *Mycobacterium tuberculosis*, certain strains of *Staphylococcus aureus* (e.g., MRSA), and *Pseudomonas aeruginosa* are notorious for their resistance to multiple antibiotics. These organisms develop resistance through various mechanisms, including **enzyme-mediated drug inactivation**, **efflux pumps**, and **alterations in target sites**.

**Why Each Wrong Option is Incorrect**
**Option A:** Without the specific option provided, it's challenging to give a precise reason, but generally, incorrect options might include organisms that are not typically known for multidrug resistance.
**Option B:** Similarly, without the option, it's hard to comment, but it could be an organism that is usually susceptible to a broad range of antibiotics.
**Option C:** Again, lacking the specific option, but it might be an organism with known susceptibility patterns that don't align with multidrug resistance.
**Option D:** This could potentially be an organism that, while it may have some resistance, does not exhibit the level of multidrug resistance as the correct answer.

**Clinical Pearl / High-Yield Fact**
A key point to remember is that **MDR organisms** often require **combination therapy** or **second-line antibiotics**, highlighting the need for antimicrobial stewardship to combat resistance.

**Correct Answer:** D. Mycobacterium tuberculosis.